Products

Human AQP9(Aquaporin 9) ELISA Kit
ELK1449
Size： Price：
48 T $320.00
96 T $458.00
Download ① Send email to us

Overview

Product name: Human AQP9(Aquaporin 9) ELISA Kit
Reactivity: Human
Alternative Names: SSC1; Aquaglyceroporin-9; Small solute channel 1
Assay Type: Sandwich
Sensitivity: 6.4 pg/mL
Standard: 1000 pg/mL
Detection Range: 15.63-1000 pg/mL
Sample Type: serum, plasma, tissue homogenates and other biological fluids
Assay Length: 3.5h
Research Area: Metabolic pathway;Infection immunity;Developmental science;
Uniprot ID: O43315
Test principle: The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human AQP9. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human AQP9. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human AQP9, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human AQP9 in the samples is then determined by comparing the OD of the samples to the standard curve.

Standard curve

Concentration (pg/mL) OD Corrected OD
1000.00 2.154 2.089
500.00 1.630 1.565
250.00 1.226 1.161
125.00 0.834 0.769
62.50 0.514 0.449
31.25 0.318 0.253
15.63 0.100 0.035
0.00 0.065 0.000

Precision

Intra-assay Precision (Precision within an assay)：CV%<8%

Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.

Inter-assay Precision (Precision between assays)：CV%<10%

Three samples of known concentration were tested in forty separate assays to assess inter-assay precision.

Recovery

Matrices listed below were spiked with certain level of recombinant AQP9 and the recovery rates were calculated by comparing the measured value to the expected amount of AQP9 in samples.
Matrix Recovery range Average
serum(n=5) 84-108% 98%
EDTA plasma(n=5) 87-96% 92%
Heparin plasma(n=5) 83-92% 85%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of AQP9 and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Matrix 1:2 1:4 1:8 1:16
serum(n=5) 79-93% 89-97% 85-94% 87-101%
EDTA plasma(n=5) 86-94% 85-95% 89-99% 85-95%
Heparin plasma(n=5) 87-96% 92-105% 89-102% 92-101%